marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-08-2024
G1 Therapeutics Financial Ratios 2011-2025 | GTHX
Annual Financial Ratios G1 Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-3.6 | -1.1 | -2.8 | -9.2 | -6.4 | -8.2 | -7.7 | - | - | - | - | - | - |
P/S |
2.1 | 3.1 | 13.4 | 20.2 | - | - | - | - | - | - | - | - | - |
EPS |
-0.9 | -3.4 | -3.5 | -2.6 | -3.3 | -2.6 | -3.6 | -23.3 | -16.1 | - | - | - | - |
EV (Enterprise Value) |
227 M | 186 M | 312 M | 758 M | 547 M | 345 M | 373 M | -41.7 M | -20.8 M | - | - | - | - |
EBITDA per Share |
-0.75 | -3.11 | -3.39 | -2.53 | -3.43 | -2.67 | -3.35 | - | - | - | - | - | - |
EV/EBITDA |
-2.2 | -7.6 | -4.0 | -3.7 | -5.9 | - | - | - | - | - | - | ||
PEG |
- | 0.46 | -0.23 | 0.29 | -0.07 | - | - | - | - | - | - | ||
P/B |
4.9 | 2.3 | 2.9 | 5.2 | 3.1 | 2.0 | 5.0 | - | - | - | - | - | - |
P/CF |
-4.5 | -1.3 | -3.2 | -10.9 | -7.7 | -9.4 | -9.2 | - | - | - | - | - | - |
ROE % |
-135.55 | -214.64 | -103.35 | -55.96 | -47.92 | -23.77 | -64.38 | - | - | - | - | - | - |
ROA % |
-39.47 | -78.50 | -58.38 | -43.43 | -42.99 | -22.97 | -57.16 | - | - | - | - | - | - |
ROCE % |
-111.70 | -198.09 | -99.24 | -54.40 | -48.68 | -24.88 | -65.23 | - | - | - | - | - | - |
Current Ratio |
1.4 | 1.6 | 2.3 | 4.5 | 13.7 | 29.9 | 8.9 | - | - | - | - | - | - |
DSO |
52.6 | 59.7 | 34.4 | 1.0 | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
52.6 | 59.7 | 34.4 | 1.0 | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
52.6 | 59.7 | 34.4 | 1.0 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios G1 Therapeutics
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.1 | -0.2 | - | -0.35 | 0.17 | -0.53 | - | -0.59 | -0.92 | -1.15 | -0.94 | -1 | -0.94 | -0.65 | -0.67 | -0.31 | -0.83 | -0.82 | -0.94 | -0.86 | -0.82 | -0.64 | -0.65 | -0.59 | -0.64 | -0.7 | -0.6 | -0.55 | -1.09 | -11.24 | -7.77 | -5.21 | -5.63 | -4.71 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.07 | -0.17 | - | -0.31 | 0.23 | -0.5 | - | -0.5 | -0.86 | -1.09 | -0.88 | -0.96 | -0.9 | -0.62 | -0.63 | -0.24 | -0.81 | -0.84 | -0.97 | -0.9 | -0.87 | -0.69 | -0.7 | -0.61 | -0.66 | -0.7 | -0.61 | -0.56 | -1.08 | -8.26 | -6.96 | -4.41 | -4.98 | -4.11 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-143.71 | -106.33 | -88.52 | -143.50 | -156.17 | -230.77 | -163.58 | -191.46 | -160.29 | -119.31 | -80.96 | -67.37 | -50.14 | -49.25 | -55.96 | -55.54 | -61.63 | -56.04 | -47.92 | -40.76 | -33.65 | -27.45 | -23.77 | -35.24 | -46.39 | -56.85 | -64.38 | -30.19 | -3.40 | 24.23 | 37.45 | 21.44 | 11.35 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-42.91 | -31.48 | -24.83 | -40.00 | -41.49 | -69.92 | -60.25 | -76.00 | -55.73 | -69.98 | -56.00 | -51.35 | -39.01 | -38.42 | -43.43 | -44.78 | -51.03 | -48.15 | -42.99 | -37.04 | -31.04 | -25.88 | -22.97 | -32.63 | -42.10 | -50.92 | -57.16 | -62.59 | -61.36 | -62.22 | -50.48 | -28.91 | -15.31 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-123.08 | -88.70 | -75.26 | -122.14 | -130.98 | -206.72 | -149.33 | -175.51 | -151.70 | -113.89 | -77.57 | -64.97 | -47.39 | -46.86 | -54.40 | -55.12 | -62.94 | -58.31 | -50.50 | -43.46 | -35.95 | -29.24 | -24.88 | -36.12 | -47.37 | -57.81 | -65.28 | -30.77 | -3.54 | 24.36 | 37.61 | 21.61 | 11.43 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.3 | 1.4 | 1.4 | 1.5 | 1.6 | 1.4 | 1.6 | 1.4 | - | 1.9 | 2.3 | 3.7 | 4.3 | 4.9 | 4.5 | 4.5 | 4.5 | 4.5 | 9.7 | 9.7 | 9.7 | 9.7 | 29.8 | 29.8 | 29.8 | 29.8 | 8.9 | 8.9 | 8.9 | 8.9 | 8.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
68.8 | 76.7 | - | 83.2 | 31.4 | 95.6 | - | 20.4 | 32.9 | 87.9 | 86.0 | 95.8 | 69.2 | 17.0 | 1.3 | 0.8 | 10.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
68.8 | 76.7 | - | 83.2 | 31.4 | 95.6 | - | 20.4 | 32.9 | 87.9 | 86.0 | 95.8 | 69.2 | 17.0 | 1.3 | 0.8 | 10.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
68.8 | 76.7 | - | 83.2 | 31.4 | 95.6 | - | 20.4 | 32.9 | 87.9 | 86.0 | 95.8 | 69.2 | 17.0 | 1.3 | 0.8 | 10.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency